Five late-stage drug candidates are drawing attention as researchers search for more effective, targeted, and convenient options for people living with ulcerative colitis.
New York,...
New partnership with Nippon Shinyaku strengthens the path toward developing and commercializing a promising therapy for patients with rare inflammatory diseases
Lausanne, Switzerland, 4 August...
Successful inspection highlights the company's commitment to quality, compliance, and reliable analytical testing for pharmaceutical development
Research Triangle Park, North Carolina, 28 July 2026 –...
New specialized division aims to improve the safe and timely delivery of medicines, medical devices, and advanced therapies worldwide
Memphis, Tennessee, 14 July 2026 –...
Imfinzi and BCG combination brings a major advancement for patients with high-risk early-stage bladder cancer
Wilmington, Delaware, 2 June 2026 – AstraZeneca has achieved a...
